Status:
UNKNOWN
Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer
Lead Sponsor:
Igenomix
Conditions:
Infertility
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This clinical validation study is being carried out to validate the efficacy of a test measuring the clinical application of prostaglandins present in the endometrial fluid in patients, 24 hours befor...
Eligibility Criteria
Inclusion
- Any IVF patient being treated for single or double embryo transfer
- BMI: 20 - 30
- Normal ovarian response (7 - 8 ovocitos) in IVF treatment with AFC ≥ 8, (AFC = Antral Follicle Count)
- Elective embryo transfer
- Normal uterine cavity
- Age: ≤ 38 years old for patients with own oocytes; ≤ 50 years old for patients with donated oocytes.
Exclusion
- Patients with recurrent miscarriages ( ≥ 2 biochemical miscarriages; ≥ 2 clinical miscarriage)
- Patients with severe male factor ( ≥ 2\*106 espermatozoides/ml).
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02189369
Start Date
February 1 2015
End Date
December 1 2017
Last Update
March 7 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación IVI
Valencia, Valencia, Spain, 46015
2
IVI Valencia
Valencia, Valencia, Spain, 46015